PDGFRA and pulmonary fibrosis: In animal models, we and others have demonstrated that treatments with imatinib, an inhibitor of PDGFR-α and -β, c-KIT, and Bcr-Abl, inhibited the development of pulmonary fibrosis in radiation- and bleomycin (BLM)-induced models [5–7].